Abbvie Inc. vs Medpace Holdings, Inc.
ABBV vs MEDP — side-by-side comparison from reported financials. ABBV leads 4, MEDP leads 5 of 9 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Medpace Holdings, Inc.
MEDP · Healthcare
$612.05+1.55%Strained
| Metric | ABBV | MEDP |
|---|---|---|
| Price | $276.43 | $612.05 |
| Market cap | $488B | $17.1B |
| Revenue (TTM) | $64.4B | $2.78B |
| Revenue growth | +1.8% | +20.1% |
| Net margin | 9.8% | 17.7% |
| Free cash flow | $18.2B | $707M |
| Net cash (debt) | ($56.2B) | — |
| 1-year price return | +19.8% | +18.0% |
| P/E | 77.4 | 34.8 |
| P/E vs own history (cheap-side %) | 23% | 30% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | 110% |
| Altman Z-score | 2.33 | — |
| CV checks passed | 9 of 11 | 8 of 11 |
| Employees | 57,000 | 6,500 |
Full résumé-style profiles: ABBV CV · MEDP CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.